Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING LLC
GLOBETECH PUBLISHING LLC
PZ HTL SA

Advanced Incubation Solution Introduced for Cell-Based Research

By BiotechDaily International staff writers
Posted on 31 Jan 2013
Image: The Thermo Scientific Cytomat 10 automated incubator (Photo courtesy of Thermo Fisher).
Image: The Thermo Scientific Cytomat 10 automated incubator (Photo courtesy of Thermo Fisher).
An automated incubator and storage module provides superior cell growth and assay incubation and a reliable thermal decontamination routine.

Thermo Fisher Scientific (Waltham, MA, USA) has now introduced the new Thermo Scientific Cytomat 10, an automated incubator and storage module designed to provide superior environmental control for cell growth and assay incubations in laboratories performing high-throughput cell biology or screening. The Cytomat 10 provides a fast plate access time of less than 10 seconds. Additionally, multiple transfer positions and an under-bench version allow flexible incubator placement within the laboratory. As the first generation of automated incubator with a fully validated thermal decontamination system, the Thermo Scientific Cytomat 10 is designed to significantly decrease the risk of contamination and reduce assay variability.

Utilizing more than 40 years of experience in CO2 incubator technology, the Thermo Scientific Cytomat 10 design provides scientists with a reliable, robust incubation unit for precious cell cultures and assays. The design virtually eliminates recovery times with a heated automatic access door, with small opening. The efficient thermal disinfection method practically eliminates germs and spore suspensions, even in areas difficult to reach via manual cleaning. Based on the trusted ContraCon Routine of the Thermo Scientific HERAcell incubators, the Cytomat 10’s decontamination is carried out in wet conditions at 90 °C, leaving incubators virtually residue-free. The Thermo Scientific Cytomat 10 incorporates humidity control via an external water reservoir, reducing the risk of contamination from an internal source and the need for repetitive incubator access.

As a flexible incubation unit, the Cytomat 10 incorporates the Thermo Scientific internally automated PSS (Plate Shuttle System) to serve multiple access and loading positions. Cytomat 10 includes an LCD monitor for incubation parameters and full text read-out messaging to inform the user of temperature, humidity, and gaseous atmosphere level changes. The unit can also be seamlessly integrated with existing automated assay hardware.

Related Links:

Thermo Fisher Scientific, Inc.
Thermo Scientific Cytomat 10





comments powered by Disqus

Channels

Genomics/Proteomics

view channel
Image: This novel, flexible film that can react to light is a promising step toward an artificial retina (Photo courtesy of the American Chemical Society).

Novel Nanofilm May Be Artificial Retina Precursor

Researchers have used advanced nanotechnology techniques to develop a light-sensitive film that has potential for future artificial retina applications. Investigators at the Hebrew University of Jerusalem... Read more

Drug Discovery

view channel
Image: Disruption and removal of malaria parasites by the experimental drug (+)-SJ733 (Photo courtesy of the University of California, San Francisco).

Experimental Antimalaria Drug Induces the Immune System to Destroy Infected Red Blood Cells

An experimental drug for the treatment of malaria was found to induce morphological changes in infected erythrocytes that enabled the immune system to recognize and eliminate them. Investigators at... Read more

Biochemistry

view channel

Blocking Enzyme Switch Turns Off Tumor Growth in T-Cell Acute Lymphoblastic Leukemia

Researchers recently reported that blocking the action of an enzyme “switch” needed to activate tumor growth is emerging as a practical strategy for treating T-cell acute lymphoblastic leukemia. An estimated 25% of the 500 US adolescents and young adults diagnosed yearly with this aggressive disease fail to respond to... Read more

Business

view channel

R&D Partnership Initiated to Reduce Development Time for New Drugs

nanoPET Pharma, GmbH (Berlin, Germany) signed an open-ended framework contract with the international pharmaceutical company Boehringer Ingelheim (Ridgefield, CT, USA). By developing customized contrast agents for research in both basic and preclinical studies, nanoPET Pharma will contribute to the enhancement of Boehringer... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.